Factors Associated With Visual Acuity and Central Subfield Thickness in Diabetic Macula Edema Treated With Anti–VEGF Therapy
This secondary analysis of the Protocol T randomized clinical trial explores additional factors that are associated with visual acuity and central subfield thickness changes when treating diabetic macular edema with anti–vascular endothelial growth factor agents. source https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2722673